DUBLIN--(BUSINESS WIRE)--The "Global Flow Diversion Aneurysm Treatment Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The analysts forecast the Global Flow Diversion ...

LONDON--(BUSINESS WIRE)--The global flow diversion aneurysm treatment market is expected to post a CAGR of 14% during the period 2018-2022, according to the latest market research report by Technavio.

A multi-center study supports the effectiveness of the newest technology available for the treatment of difficult, life-threatening brain aneurysms. The technology, the Pipeline embolization device, ...

Aneurysms of the paraclinoid region of the internal carotid artery (ICA) and the interventions used to treat them often result in visual impairment. Researchers, however, found that flow diversion ...

HOUSTON, Texas — Flow diversion therapy with the Pipeline Embolization Device (PED; Medtronic), used in the treatment of large aneurysms, now shows high rates of occlusion success in the treatment of ...

CINCINNATI—A multi-center study supports the effectiveness of the newest technology available for the treatment of difficult, life-threatening brain aneurysms. The technology, the Pipeline ...

LOS ANGELES, NeuroSigma ®, Inc. (NeuroSigma), a California-based life sciences company, today announced that results of an animal study of its Thin Film Nitinol (TFN) flow diverter were presented on ...

A U.S. Food and Drug Administration advisory committee will meet this week to evaluate the clinical evidence for new devices designed to treat unruptured brain aneurysms. This is a growing clinical ...

Aneurysms of the paraclinoid region of the internal carotid artery (ICA) and the interventions used to treat them often result in visual impairment. Researchers at Brigham and Women's Hospital, ...